Company News
https://chimebiologics.com/wp-content/uploads/2026/04/KV-Website-EN.png
641
1326
chi9iua
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
chi9iua2026-04-03 09:50:042026-04-08 17:34:13Winning in Biosimilars: Speed, Scale, and the New Competitive Playbook
https://chimebiologics.com/wp-content/uploads/2026/04/KV3-InvitationLetter-BioEquity2026.png
766
1240
chi9iua
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
chi9iua2026-04-01 13:58:492026-04-01 14:58:44BioEquity Europe 2026
https://chimebiologics.com/wp-content/uploads/2026/03/image1-chime.png
380
900
chi9iua
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
chi9iua2026-03-27 14:47:042026-03-27 16:44:27Chime Biologics Congratulates Hope Medicine Inc. on Successful Dosing of First Patient in Phase III Clinical Trial for Endometriosis in China
Biosimilars: Forging a New Path to Accessibility Amid the Reshaping of the Global Biologics Industry
https://chimebiologics.com/wp-content/uploads/2025/12/合作banner英文2.jpg
320
750
chi9iua
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
chi9iua2025-12-10 10:15:032026-01-16 16:12:28Chime Biologics Announces Strategic Collaboration with Beijing Libang Pharmaceutical on Global Blinatumomab Biosimilar Program
https://chimebiologics.com/wp-content/uploads/2025/12/合作banner-3.jpg
320
750
chi9iua
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
chi9iua2025-12-09 16:07:592026-01-16 16:11:38Chime Biologics Announces Strategic Collaboration with TNAX Biopharma, Marking Its First Partnership in Japan

